PBSC mobilization, grafts, and engraftment
| . | Median . | Range . | No. patients . |
|---|---|---|---|
| Mobilization and grafts | |||
| Number of aphereses* | 3 | 2 -7 | 19 |
| CD34+ cells × 106/kg | 4.2 | 2.7 -7.4 | 19 |
| Purity (%) | 91.5 | 55 -96 | 19 |
| T cells × 104/kg† | 3.6 | 0 -25.2 | 17 |
| Engraftment | |||
| Days to ANC > 500/μL‡ | 9 | 7 -13 | 19 |
| Days to platelets > 20 000/μL‡ | 10 | 9 -25 | 19 |
| . | Median . | Range . | No. patients . |
|---|---|---|---|
| Mobilization and grafts | |||
| Number of aphereses* | 3 | 2 -7 | 19 |
| CD34+ cells × 106/kg | 4.2 | 2.7 -7.4 | 19 |
| Purity (%) | 91.5 | 55 -96 | 19 |
| T cells × 104/kg† | 3.6 | 0 -25.2 | 17 |
| Engraftment | |||
| Days to ANC > 500/μL‡ | 9 | 7 -13 | 19 |
| Days to platelets > 20 000/μL‡ | 10 | 9 -25 | 19 |